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Letters to the Editoreither cerebral infarction or hemor-
rhage after early surgical treatment,
compared with 8% in the late opera-
tion group. Facing these results, one
should keep in mind the recommenda-
tions by the Society of Thoracic
Surgeons Clinical Practice Guide-
lines4 to delay surgery for at least
4 weeks if possible for patients who
have had a major ischemic stroke or
any intracranial hemorrhage.
Finally, we are interested in the
results of intraoperative valve cultures
and pathologic examination of in-
fected valves. How many patients
showed traces of active endocarditis
during surgery? Was this associated
with the fairly high risk of reoperation
during follow-up (9%-12%)?
In conclusion, we could say that this
study shows a lower in-hospital mor-
tality in the early surgery group at the
expense of worse neurologic out-
comes. We think that if one does not
know the indications for early surgery,
a judgment on the outcomes of surgery
will be questionable. Referring to
these concerns, we consider the data
presented not convincing for dropping
a patient-tailored approach in favor of
a priori early surgical treatment.
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BYPASSGRAFTINGINISOLATED
LIFE-THREATENING RIGHT
VENTRICULAR FAILURE AFTER
AORTIC VALVE REPLACEMENT
To the Editor:
Coronary ostial damage is a rare but
potentially serious sequela after aortic
valve replacement. It occurs in the left
main or right coronary artery after 1%
to 5% of aortic valve replacement pro-
cedures.This lethal conditionmaypres-
ent with difficulty in weaning from
cardiopulmonary bypass pump; echo-
cardiographic signs of major wall
motion abnormalities; or electrocardio-
graphic evidence of ischemia, pump
failure, and ventricular arrhythmias.
The outcomes are usually severe and
may appear immediately during sur-
gery. The typical treatment in
operating is coronary artery bypass
grafting.1
Here we present the case of a patient
with bicuspid aortic valve and severe
aortic stenosis who underwent Man-
aguan surgery associated with aortic
valve replacement with a 23-mm diam-
etermechanical valve (St JudeMedical,
Inc, St Paul, Minn), and cardioplegic
solution was administered antegradely.
Right ventricular failure unexpectedly
occurred in the operating room after
aortic valve replacement, and the pa-
tient could not be separated from the
cardiopulmonary bypass pump. This
problem was not resolved by medica-
tion. Intraoperative transesophageal
echocardiography showed a well-
functioning mechanical prosthesis
with no evidence of paravalvular leak-
age, air emboli, interfering mechanical
aortic valve with the ostial rightCardiovascular Surgery c December 20coronary artery or any regional wall
motion abnormality. Intraoperative
transesophageal echocardiography re-
vealed severe right ventricular failure
with normal inferior wall motion de-
spite the major perfusion of inferior
segment by the right coronary artery.
Preoperative echocardiography
showed onlymild right ventricular dys-
function before surgery. There was no
ST elevation on electrocardiographic
monitoring. Finally, the patient under-
went bypass grafting of the saphenous
vein to the right coronary artery with
possibility of right coronary artery
obstruction. Interestingly, she was suc-
cessfully separated from the cardiopul-
monary bypass pump, and shewaswell
during hospital stay. The follow-up cor-
onary computed tomographic angiog-
raphy showed obstruction of the
right coronary artery ostium by me-
chanical prostheses. She was dis-
charged, and her midterm follow-up
was uneventful.
When right ventricular failure oc-
curs during aortic valvular operation,
inadequate myocardial protection
may be the culprit. Other causes of
right ventricular failure should be con-
sidered, such as air or particulate mat-
ter embolization. Right ventricular
failure that unexpectedly occurs dur-
ing an aortic valvular operation most
probablywould be due to amechanical
problem with the right coronary
ostium.2-5
We concluded that when right ven-
tricular failure unexpectedly occurs
during an aortic valvular operation
and does not improvewith reperfusion
and auxiliary medications, a mechani-
cal problem in the right coronary
artery should be considered even
with normal motion in inferior wall
and normal findings on electrocardio-
graphic monitoring. This rare compli-
cation could be life threatening if not
promptly recognized. Consequently,
it is important to have an high index
of diagnostic suspicion. Rescue coro-
nary artery bypass grafting in this
situation would be lifesaving.12
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OUTCOMES IN OLDER ADULTS
AFTER TRANSCATHETER
AORTIC VALVE
REPLACEMENT
To the Editor:
Transcatheter aortic valve replace-
ment (TAVR), an approach developed
for older, frail patients at risk for
open cardiac operations represents
24% of all procedures for the treat-
ment of aortic stenosis in GermanyThe Journaland was recently approved by the
Food and Drug Administration.
Despite the benefits of avoiding
open surgery, TAVR has been associ-
ated with more than tripling the rate
of stroke in inoperable candidates ver-
sus medical therapy controls1 and
a doubling of the stroke rate in high-
risk participants versus high-risk oper-
ative controls.2 The incidence of acute
hyperintensities or ischemia-like le-
sions on diffusion-weighted magnetic
resonance imaging (MRI) of the brain
is double what has been historically
reported for surgical aortic valve re-
placement (AVR).3,4 Furthermore,
the risk of neurologic events in
TAVR patients remains considerably
elevated relative to AVR at 24
months after the procedure.2 Studies
examining outcomes of TAVR
have conducted only gross clinical
evaluations of neurocognitive func-
tion in the relative short term;
the longer-term implications of ‘‘neu-
rologic events’’ and MRI lesions for
older adults after TAVR and many
other cardiovascular procedures have
not been extensively studied.
Although it is intuitive to expect
less-invasive approaches to yield im-
proved outcomes, recent history has
shown that this may not be the case.
The less-invasive ‘‘off-pump’’ ap-
proach to coronary artery bypass graft-
ing was primarily developed to avoid
stroke and cognitive dysfunction
thought to be caused by exposure to
cardiopulmonary bypass, but studies
have not conclusively demonstrated
any real benefit in the incidence of
stroke or postoperative cognitive im-
pairment. The push to implement the
off-pump approach for its perceived
neurologic benefits may have actually
worsened long-term cardiac outcomes
because of the technical challenges as-
sociatedwith revascularizing a beating
heart.5 In light of this historical per-
spective, the lack of mortality benefit
from TAVR over AVR at 1 year,6 in-
creased stroke rate in TAVR patients,
and the increase in ischemic lesions
on MRI after TAVR, we are left toof Thoracic and Cardiovascular Surgerwonder just what real benefit this
less-invasive approach offers.
The largest long-term studies of
neurocognitive outcomes after cardiac
procedures have focused on relatively
younger patients undergoing bypass
grafting and might underestimate the
long-term impact in older adults un-
dergoing different cardiovascular pro-
cedures associated with higher rates of
stroke, cerebral emboli, or greater
cognitive decline. Future research on
neurocognitive outcomes from TAVR
is necessary to determine the neuro-
cognitive risks and benefits associated
with this new procedure as well as the
potential need for adjunctive neuro-
logic interventions.
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